This unique blood test uses two critical prognostic factors, pre-therapy clearance and genetics, to help guide therapeutic selection. Knowing an inflammatory bowel disease patient's likelihood of ...
The San Diego-based pharmaceutical company Prometheus Laboratories has launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab. 1. The PROMETHEUS ...
The MarketWatch News Department was not involved in the creation of this content. New Therapeutic Drug Monitoring Test for Interleukin--23 Inhibitor SAN DIEGO, CA / ACCESS Newswire / April 1, 2025 / ...
WASHINGTON — The Supreme Court has tossed out a medical patent for Prometheus Laboratories, a decision that could affect the burgeoning field of personalized medicine. The justices on Tuesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback